High risk of stroke in ANCA-associated vasculitis-a population-based study
- PMID: 36440920
- PMCID: PMC10393431
- DOI: 10.1093/rheumatology/keac669
High risk of stroke in ANCA-associated vasculitis-a population-based study
Abstract
Objective: To determine the incidence rate, predictors and outcome of stroke in a population-based cohort of individuals with ANCA-associated vasculitis (AAV).
Methods: The study included 325 patients diagnosed with AAV from 1997 through 2016 in a defined geographic area of Sweden. Patients who suffered a stroke were identified from Riksstroke, a national Swedish stroke register established in 1994, and the Skåne Healthcare Register (SHR), which includes data for all inhabitants of Skåne since 1998. Case record review was carried out to confirm the diagnosis of stroke in AAV patients identified in the SHR. The incidence rate of stroke was calculated per 1000 person-years of follow-up. Using data from the Swedish general population, the standardized incidence ratio (SIR) of stroke was estimated. Cox regression analysis was utilized to investigate survival and predictors of stroke.
Results: Twenty-five subjects (8%) suffered a stroke during 2206 person-years of follow-up. The incidence rate of stroke in AAV was 11.3/1000 person-years (95% CI 6.9, 15.8). Patients with AAV showed an increased risk of stroke compared with the general population [SIR 1.85 (95% CI 1.27, 2.59)], with a greater risk for those <65 years of age [SIR 3.19 (95% CI 1.53, 5.88)]. Higher platelet count at AAV diagnosis was an independent predictor of stroke [hazard ratio 1.14 (95% CI 1.00, 1.29)]. There were no differences in survival or other outcome measures between AAV patients with and without stroke.
Conclusions: The incidence rate of stroke in AAV is higher than in the general population. High platelet count at AAV diagnosis was associated with an increased risk of stroke.
Keywords: ANCA; epidemiology; population-based study; stroke; vasculitis.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Figures
Similar articles
-
Thyroid disease in ANCA-associated vasculitis: a clinical and epidemiological study.RMD Open. 2024 Apr 30;10(2):e003996. doi: 10.1136/rmdopen-2023-003996. RMD Open. 2024. PMID: 38688691 Free PMC article.
-
Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort study.Rheumatology (Oxford). 2021 Oct 2;60(10):4616-4623. doi: 10.1093/rheumatology/keab057. Rheumatology (Oxford). 2021. PMID: 33506869
-
Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study.Rheumatology (Oxford). 2021 Jun 18;60(6):2745-2754. doi: 10.1093/rheumatology/keaa699. Rheumatology (Oxford). 2021. PMID: 33253372
-
Antineutrophil Cytoplasmic Autoantibodies-Associated Vasculitides and Risk of Stroke: A Systematic Review and Meta-analysis.Neurol India. 2022 Sep-Oct;70(5):1868-1873. doi: 10.4103/0028-3886.359250. Neurol India. 2022. PMID: 36352580 Review.
-
Clinical characteristics and primary outcomes of patients with ANCA-associated vasculitis and central diabetes insipidus.Front Endocrinol (Lausanne). 2023 May 12;14:1173903. doi: 10.3389/fendo.2023.1173903. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37251686 Free PMC article. Review.
Cited by
-
The monocyte-to-high-density lipoprotein-cholesterol ratio at diagnosis is associated with cerebrovascular accident during follow-up in patients with antineutrophil cytoplasmic antibody-associated vasculitis.J Rheum Dis. 2024 Jul 1;31(3):151-159. doi: 10.4078/jrd.2024.0001. Epub 2024 Mar 12. J Rheum Dis. 2024. PMID: 38957360 Free PMC article.
-
Thyroid disease in ANCA-associated vasculitis: a clinical and epidemiological study.RMD Open. 2024 Apr 30;10(2):e003996. doi: 10.1136/rmdopen-2023-003996. RMD Open. 2024. PMID: 38688691 Free PMC article.
-
Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden.RMD Open. 2024 Apr 10;10(2):e003960. doi: 10.1136/rmdopen-2023-003960. RMD Open. 2024. PMID: 38599652 Free PMC article.
-
Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?Clin Kidney J. 2022 Jan 13;15(4):618-623. doi: 10.1093/ckj/sfac009. eCollection 2022 Apr. Clin Kidney J. 2022. PMID: 35371453 Free PMC article.
References
-
- Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76–85. - PubMed
-
- Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M. Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 2009;48:1560–5. - PubMed
-
- Englund M, Merkel PA, Tomasson G, Segelmark M, Mohammad AJ. Comorbidities in patients with antineutrophil cytoplasmic antibody-associated vasculitis versus the general population. J Rheumatol 2016;43:1553–8. - PubMed
-
- Trieste L, Palla I, Baldini C et al. Systemic vasculitis: how little we know about their societal and economic burden. Clin Exp Rheumatol 2012;30(4 Suppl 73):S154–6. - PubMed
-
- Faurschou M, Mellemkjaer L, Sorensen IJ et al. Increased morbidity from ischemic heart disease in patients with Wegener’s granulomatosis. Arthritis Rheum 2009;60:1187–92. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
